IMPROVEMENT OF INFLAMMATORY BIOMARKERS, LIVER FIBROSIS AND CLINICAL PARAMETERS WITH 3 MONTHS ZINC SULFATE FOR ALCOHOLIC CIRRHOSIS-ZAC CLINICAL TRIAL

被引:0
|
作者
Mohammad, M. K. [1 ]
Song, M. [1 ]
Falkner, K. C. [1 ]
McClain, C. J. [1 ]
Cave, M. [1 ]
机构
[1] Univ Louisville, Dept Med, Robley Rex VAMC, Louisville, KY 40292 USA
关键词
D O I
暂无
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
914
引用
收藏
页码:239A / 239A
页数:1
相关论文
共 50 条
  • [1] Improvement of Inflammatory Biomarkers, Liver Fibrosis, Liver Functions & Clinical Parameters With Three Months Supplementation of (220mg) Zinc Sulfate for Alcoholic Cirrhosis (ZAC) - Clinical Trial
    Mohammad, K. Mohammad
    Song, Ming
    Falkner, Keith C.
    McClain, Craig J.
    Cave, Matthew C.
    GASTROENTEROLOGY, 2015, 148 (04) : S972 - S972
  • [2] Zinc Sulfate for Alcoholic Cirrhosis (ZAC) Clinical Trial - Interim Analysis of Clinical Parameters, Intestinal Permeability and Liver Fibrosis Biomarkers
    Song, Ming
    Mohammad, Mohammad K.
    Falkner, Keith C.
    McClain, Craig J.
    Cave, Matthew C.
    HEPATOLOGY, 2014, 60 : 787A - 787A
  • [3] Zinc Sulfate for Alcoholic Cirrhosis (ZAC) Clinical Trial - Interim Analysis of Liver Injury/Inflammation Biomarkers
    Mohammad, Mohammad K.
    Song, Ming
    Falkner, Keith C.
    McClain, Craig J.
    Cave, Matthew C.
    HEPATOLOGY, 2014, 60 : 794A - 794A
  • [4] Low Dose Zinc Sulfate (220mg) Supplementation for Three Months Normalizes Zinc Levels, Endotoxeima, Pro-Inflammatory/Fibrotic Biomarkers & Improves Clinical Parameters in Alcoholic Cirrhosis-A Double-Blind Placebo Controlled - (ZAC) Clinical Trial
    Mohammad, Mohammad K.
    Falkner, Keith C.
    Song, Ming
    McClain, Craig J.
    Cave, Matthew C.
    HEPATOLOGY, 2015, 62 : 851A - 852A
  • [5] CLINICAL AND PRONOSTIC VALUE OF THE QUANTIFIED FIBROSIS IN ALCOHOLIC LIVER CIRRHOSIS
    REIMERS, EG
    FERNANDEZ, FS
    PESTANA, MP
    HERNANDEZ, JAJ
    LOPEZ, NB
    GONZALEZ, JA
    NIETO, LH
    REVISTA ESPANOLA DE LAS ENFERMEDADES DEL APARATO DIGESTIVO, 1985, 68 (05): : 413 - 419
  • [6] ZINC SUPPLEMENTATION IN ALCOHOLIC CIRRHOSIS - DOUBLE-BLIND CLINICAL-TRIAL
    WEISMANN, K
    CHRISTENSEN, E
    DREYER, V
    ACTA MEDICA SCANDINAVICA, 1979, 205 (05): : 361 - 366
  • [7] Clinical parameters and inflammatory biomarkers among patients with multibracket appliances: a prospective clinical trial
    Peron, Priscila Ferrari
    Wehrbein, Heinrich
    Mundethu, Ambili
    Schmidtmann, Irene
    Erbe, Christina
    BMC ORAL HEALTH, 2024, 24 (01)
  • [8] Clinical parameters and inflammatory biomarkers among patients with multibracket appliances: a prospective clinical trial
    Priscila Ferrari Peron
    Heinrich Wehrbein
    Ambili Mundethu
    Irene Schmidtmann
    Christina Erbe
    BMC Oral Health, 24
  • [9] Effects of Low Dose Zinc Supplementation on Biochemical Markers in Non-alcoholic Cirrhosis: A Randomized Clinical Trial
    Somi, Mohammad Hossein
    Rezaeifar, Parisa
    Rahimi, Alireza Ostad
    Moshrefi, Behnaz
    ARCHIVES OF IRANIAN MEDICINE, 2012, 15 (08) : 472 - 476
  • [10] Does vitamin D improve liver enzymes, oxidative stress, and inflammatory biomarkers in adults with non-alcoholic fatty liver disease? A randomized clinical trial
    Sharifi, Nasrin
    Amani, Reza
    Hajiani, Eskandar
    Cheraghian, Bahman
    ENDOCRINE, 2014, 47 (01) : 70 - 80